CRISPR in der biotechnologischen Forschung und Entwicklung
The discovery of programmable double-stranded DNA specific nucleases derived from the prokaryotic immunity systems CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) has opened a new era of genome editing and its applications in industrial biotechnology. Simple reprogramming of the DNA-specificity of CRISPR nucleases by RNAs allows the engineering of novel eukaryotic screening or producer cells through gene knock-out, chromosomal deletion and the regulation of gene expression.
Unable to display preview. Download preview PDF.